Senate Drug Pricing Bill Lowers Manufacturer Discounts In Part D Catastrophic Phase

 
• By Cathy Kelly

Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.

Capitol Building, Washington DC
Action On Drug Pricing Legislation Heating Up

More from Pricing Debate

More from Market Access